back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-09-06 11:58 Tx date 2019-09-06 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
37 - Stock split or consolidation
|
-175,528 vol |
172 | |
| Filed 2019-09-04 17:01 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-31,950
-22,500 vol $1.42 each |
175,700 | |
| Filed 2019-09-04 17:01 Tx date 2019-09-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
99 - Correction of information
|
$-12,168
-31,200 vol $0.39 each |
198,200 | |
| Filed 2019-06-21 13:24 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-158,500
-50,000 vol $3.17 each |
8,125,000 | |
| Filed 2019-06-21 13:23 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-60,000
-20,000 vol $3.00 each |
8,175,000 | |
| Filed 2019-06-21 13:22 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-72,450
-35,000 vol $2.07 each |
8,195,000 | |
| Filed 2019-06-21 13:21 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
97 - Other
|
$-90,090
-117,000 vol $0.77 each |
8,230,000 | |
| Filed 2019-06-21 13:20 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$50,625
+1,875,000 vol $0.027 each |
8,347,000 | |
| Filed 2019-06-21 13:20 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$168,750
+6,250,000 vol $0.027 each |
6,472,000 | |
| Filed 2019-06-20 11:41 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
57 - Exercise of rights
|
$-63.612
-4,185 vol $0.0152 each |
0 | |
| Filed 2019-06-20 10:59 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
58 - Expiration of rights
|
$-63.612
-4,185 vol $0.0152 each |
0 | |
| Filed 2019-06-20 10:59 Tx date 2019-06-14 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
58 - Expiration of rights
|
$-63.612
-4,185 vol $0.0152 each |
||
| Filed 2019-06-20 10:57 Tx date 2019-06-19 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,272
+83,700 vol $0.0152 each |
87,885 | |
| Filed 2019-06-20 10:56 Tx date 2019-05-24 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
56 - Grant of rights
|
$63.61
+4,185 vol $0.0152 each |
4,185 | |
| Filed 2019-06-20 10:42 Tx date 2016-08-10 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-06 Tx date 2018-12-31 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
58 - Expiration of rights
|
$-81,795
-28,500 vol $2.87 each |
229,400 | |
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
||
| Filed 2019-02-01 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$48,672
+124,800 vol $0.39 each |
257,900 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$36,504
+93,600 vol $0.39 each |
226,700 | |
| Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$90,090
+117,000 vol $0.77 each |
222,000 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$117,150
+82,500 vol $1.42 each |
140,300 | |
| Filed 2017-12-20 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
||
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,295.6652
-3,988 vol $1.33 each |
4,185 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-20,664
-7,200 vol $2.87 each |
110,600 | |
| Filed 2017-12-08 Tx date 2017-12-04 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$20,664
+7,200 vol $2.87 each |
8,173 | |
| Filed 2017-11-28 Tx date 2017-11-23 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$85,200
+60,000 vol $1.42 each |
117,800 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
57 - Exercise of rights
|
$-6,314
-2,200 vol $2.87 each |
57,800 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,851.4203
-1,227 vol $1.51 each |
973 | |
| Filed 2017-11-11 Tx date 2017-11-06 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,314
+2,200 vol $2.87 each |
2,200 | |
| Filed 2017-11-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-23 Tx date 2017-05-18 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$72,450
+35,000 vol $2.07 each |
105,000 | |
| Filed 2016-10-16 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-10-16 Tx date 2016-10-11 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Unités d'actions restreintes / Restricted Share Units
56 - Grant of rights
|
$172,200
+60,000 vol $2.87 each |
60,000 | |
| Filed 2016-08-11 Tx date 2016-08-10 |
$PLI
ProMetic Life Sciences Inc. |
Duguay, Rachel
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,000 |